A new site in Seattle has begun enrolling patients in an early-stage clinical trial testing CER-1236, an experimental cell therapy…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Adding medications to combat anemia to treatment with the approved myelofibrosis drug Jakavi (ruxolitinib), sold as Jakafi in the…
Halozyme Therapeutics and Incyte are partnering to develop an under-the-skin (subcutaneous) formulation of INCA033989, Incyte’s therapy candidate for…